Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Hotspot U2AF1 Mutations Determine Missplicing Selectivity: Novel Mechanisms Altering Splicing Factors

Vera Adema, PhD, Courtney E Hershberger, BS, Wencke Walter, PhD, Cassandra M Kerr, MS, Stephan Hutter, PhD, Yasunobu Nagata, MD PhD, Hassan Awada, Sunisa Kongkiatkamon, Christina Snider, Milo Co, Manja Meggendorfer, PhD, Aziz Nazha, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Francesc Sole, PhD, Richard A Padgett, PhD, Torsten Haferlach, MD, Jaroslaw P. Maciejewski, MD PhD, Valeria Visconte, PhD

Blood (2019) 134 (Supplement_1): 2985.

https://doi.org/10.1182/blood-2019-129367

Published: 2019

Journal Articles

Real-World Utilization and Safety of Daratumumab Rapid Infusion Administered in a Community Setting: A Retrospective Observational Study

Lucio Gordon, MD, Melody Chang, RPh, MBA, Marie-Hélène Lafeuille, MA, Hela Romdhani, PhD, Faud Paramasivam, Xinmei Zhu, PhD, Sriya Gunawardena, Eric M Maiese, PhD

Blood (2019) 134 (Supplement_1): 5575.

https://doi.org/10.1182/blood-2019-128515

Published: 2019

Journal Articles

A Multicenter, Open Label, Phase 3 Study of Tabelecleucel for Solid Organ Transplant Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease (EBV + PTLD) after Failure of Rituximab or Rituximab and Chemotherapy

Susan Prockop, MD, Minoti Hiremath, MBBS, PhD, Wei Ye, PhD, Laurence Gamelin, MD, Willis Navarro, MD, Kris Michael Mahadeo, MD

Blood (2019) 134 (Supplement_1): 5326.

https://doi.org/10.1182/blood-2019-129277

Published: 2019

Journal Articles

Platelet Tissue Factor Activity Is Specifically Induced By Gpib Activation Pathway, Independent of GPVI, α IIb β and Protein Disulfide Isomerase Activities

Olga Panes, BM, BCh, Valeria Matus, PhD, Claudia G Sáez, PhD, Jaime Pereira, MD, Luz María Pozo, BCh, Diego Mezzano, MD

Blood (2017) 130 (Supplement 1): 2305.

https://doi.org/10.1182/blood.V130.Suppl_1.2305.2305

Published: 2017

Journal Articles

Monomorphic Post Transplant Lymphoproliferative Disorder (Diffuse Large B Cell Lymphoma subtype) Successfully Treated without Chemotherapy after Solid Organ Transplant in Children

Marta Rojas Vasquez, MD FRCPC, Sunil J. Desai, MRCP, FRCPC, BM, BCh, Anthea Peters, MSc, MD FRCPC, Simon Urschel, MDFAKJ, Jason Yap, MDFRCPC, Raymond Lai, PhD MD, Catherine Morgan, MDFRCPC, Jutta Preiksaitis, MDFRCPC

Blood (2017) 130 (Supplement 1): 1579.

https://doi.org/10.1182/blood.V130.Suppl_1.1579.1579

Published: 2017

Journal Articles

A Single-Center Retrospective Study of 140 Patients with Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplantation

Michael D Jain, PhD MD, Ryan Lam, Rashmi S Goswami, MD, Krystyna Tybinkowski, Parneet K Cheema, MD, Atul Humar, MD MSc, Richard Tsang, MD, David Hodgson, MD, Anca Prica, MD, Vishal Kukreti, MD, Michael Crump, MD, John Kuruvilla, MD

Blood (2016) 128 (22): 4227.

https://doi.org/10.1182/blood.V128.22.4227.4227

Published: 2016

Journal Articles

ITP or Not-ITP - a Rare Case of PTLD Recurrence Presenting As Autoimmune Thrombocytopenia

Vikas Kumar Singh, MD, Margaret Means, Danh Pham, MD, Goetz H Kloecker, MD

Blood (2016) 128 (22): 4942.

https://doi.org/10.1182/blood.V128.22.4942.4942

Published: 2016

Journal Articles

a Diversity of Human Hematopoietic Differentiation Programs Identified through In Vivo Tracking of Hematopoiesis in Wiskott-Aldrich Syndrome Patients

Emmanuelle Six, PhD, Laure Caccavelli, Arnaud Lecoules, Christopher L Nobles, PhD, France Male, Cécile Roudaut, MSc, Clemence Plantier, Alessandra Magnani, MD PhD, Elisa Magrin, PhD, Nicolas Cagnard, Anne Galy, PharmD, PhD, Adrian J Thrasher, MD PhD, Salima hacein-Bey Abina, Agathe Guilloux, Isabelle Andre-Schmutz, Charles C. Berry, frederic D. Bushman, Marina Cavazzana, MD PhD

Blood (2016) 128 (22): 3871.

https://doi.org/10.1182/blood.V128.22.3871.3871

Published: 2016

Journal Articles

Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder (HL-PTLD) after Solid Organ Transplant (SOT): A Comprehensive and Comparative Analysis of Disease Characteristics, Prognosis, and Survival

Aaron S. Rosenberg, MD, Andreas K. Klein, MD, Robin Ruthazer, MPH, Andrew M. Evens, DO, MSc

Blood (2014) 124 (21): 502.

https://doi.org/10.1182/blood.V124.21.502.502

Published: 2014

Journal Articles

The Outcome Of Patients With Post Transplant and Immunodeficiency Associated Lymphoproliferative Disorder: The BCCA Experience

Amrit Kahlon, MD, Graham W. Slack, MD, Yuhua Sun, MD, Richard Klasa, MD, Laurie H. Sehn, MD, MPH, Diego Villa, MD, MPH, Tamara Shenkier, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Kerry J. Savage, MD, MSc

Blood (2013) 122 (21): 4390.

https://doi.org/10.1182/blood.V122.21.4390.4390

Published: 2013

Journal Articles

Tissue Factor-Dependent Pro-Coagulant Activity Of Human Platelets Is Directly Related To Membrane Cholesterol Content. Rosuvastatin, But Not Atorvastatin, Reduces The Platelet Cholesterol, Tissue Factor Protein and Clotting Activity In Hypercholesterolemic Patients

Olga Panes, Juan P. Valderas, M.D., Mónica Acevedo, M.D., Susana Contreras, Jaime Pereira, M.D., Attilio Rigotti, M.D., PhD., Diego Mezzano, M.D.

Blood (2013) 122 (21): 34.

https://doi.org/10.1182/blood.V122.21.34.34

Published: 2013

Journal Articles

Intravenous Busulfan-Based Myeloablative Conditioning Is Comparable to TBI-Based Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Recipients with Acute Myeloid Leukemia: A Nationwide Retrospective Study From the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation

Takuya Yamashita, M.D., Ph.D., Takahiro Fukuda, MD, PhD, Shuichi Taniguchi, MD, PhD, Kazuteru Ohashi, M.D., Saiko Kurosawa, M.D., Yasuo Morishima, M.D., Tokiko Nagamura, MD, PhD, Hisashi Sakamaki, MD, Yoshiko Atsuta, MD, PhD, Akiyoshi Takami, MD, PhD, FJSIM

Blood (2012) 120 (21): 1922.

https://doi.org/10.1182/blood.V120.21.1922.1922

Published: 2012

Journal Articles

Post-Transplant Lymphoproliferative Disorder in Lung Transplant Recipients – a Shift Lo Late Onset Disease

Eli Muchtar, MD, Liat Vidal, MD, Ron Ram, MD, Ronit Gurion, MD, Yivgenia Rosenblat, MD, Ilana Bakal, RN, Mordechai Kramer, MD, FCCP, Ofer Shpilberg, MD, MPH

Blood (2012) 120 (21): 5075.

https://doi.org/10.1182/blood.V120.21.5075.5075

Published: 2012

Journal Articles

hDLG Associated Protein 1 (DLGAP1) Supports Mpl-Driven Cell Proliferation and Differentiation Through Its Centrosomal Function,

Boguslaw A. Kwiatkowski, Ph.D., Robert E. Richard, MD, PhD

Blood (2011) 118 (21): 3402.

https://doi.org/10.1182/blood.V118.21.3402.3402

Published: 2011

Journal Articles

Sox4 and CREB Cooperate in Myeloid Transformation,

Salemiz Sandoval, Ph.D., Michelle Cho, Christina Kraus, Er-Chieh Cho, Ph.D., Linda Wolff, PhD, Kathleen M Sakamoto, MD, PhD

Blood (2011) 118 (21): 3452.

https://doi.org/10.1182/blood.V118.21.3452.3452

Published: 2011

Journal Articles

Integration-Mediated Activation of PRDM16 and HMGA2 in Multiple Clones without Adverse Hematopoietic Consequences Following Transplant of Autologous MGMTP140K Gene-Modified CD34 + Cells

Jennifer E Adair, PhD, Brian C Beard, PhD, Grant Trobridge, PhD, Frederic Bushman, PhD, Maciej M Mrugala, MD PhD, Hans-Peter Kiem, MD

Blood (2011) 118 (21): 2053.

https://doi.org/10.1182/blood.V118.21.2053.2053

Published: 2011

Journal Articles

Lymphopenia and EBER-Negativity Predict Poor Survival in Patients with Post-Transplant Lymphoproliferative Disorder (PTLD) Treated in the Rituximab Era

Anthea Peters, MD, MSc, FRCPC, Carolyn J Owen, MD, FRCPC, Karen Doucette, MD, FRCPC, Jutta Preiksaitis, MD, FRCPC

Blood (2011) 118 (21): 1645.

https://doi.org/10.1182/blood.V118.21.1645.1645

Published: 2011

Journal Articles

Relapse of Lymphoma After Allogeneic Hematopoietic Cell Transplantation: Management Strategies and Outcome.

Kitsada Wudhikarn, MD, Qing Cao, MS, Claudio Brunstein, MD, Veronika Bachanova, Linda J Burns, MD, Daniel J. Weisdorf, MD

Blood (2010) 116 (21): 4503.

https://doi.org/10.1182/blood.V116.21.4503.4503

Published: 2010

Journal Articles

Identification of Genes Cooperating with Mpl Signaling Using Retroviral Insertional Mutagenesis.

Boguslaw A. Kwiatkowski, Ph.D., Robert E. Richard, MD, PhD

Blood (2009) 114 (22): 4558.

https://doi.org/10.1182/blood.V114.22.4558.4558

Published: 2009

Journal Articles

Angiotensin II Receptor-Associated Protein (AGTRAP) Synergizes with Mpl Signaling to Promote Survival and to Increase Proliferation Rate of Hematopoietic Cells.

Boguslaw A. Kwiatkowski, Ph.D., Robert E. Richard, MD, PhD

Blood (2009) 114 (22): 3606.

https://doi.org/10.1182/blood.V114.22.3606.3606

Published: 2009

NARROW

Hotspot U2AF1 Mutations Determine Missplicing Selectivity: Novel Mechanisms Altering Splicing Factors

Real-World Utilization and Safety of Daratumumab Rapid Infusion Administered in a Community Setting: A Retrospective Observational Study

A Multicenter, Open Label, Phase 3 Study of Tabelecleucel for Solid Organ Transplant Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease (EBV + PTLD) after Failure of Rituximab or Rituximab and Chemotherapy

Platelet Tissue Factor Activity Is Specifically Induced By Gpib Activation Pathway, Independent of GPVI, α IIb β and Protein Disulfide Isomerase Activities

Monomorphic Post Transplant Lymphoproliferative Disorder (Diffuse Large B Cell Lymphoma subtype) Successfully Treated without Chemotherapy after Solid Organ Transplant in Children

A Single-Center Retrospective Study of 140 Patients with Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplantation

ITP or Not-ITP - a Rare Case of PTLD Recurrence Presenting As Autoimmune Thrombocytopenia

a Diversity of Human Hematopoietic Differentiation Programs Identified through In Vivo Tracking of Hematopoiesis in Wiskott-Aldrich Syndrome Patients

Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder (HL-PTLD) after Solid Organ Transplant (SOT): A Comprehensive and Comparative Analysis of Disease Characteristics, Prognosis, and Survival

The Outcome Of Patients With Post Transplant and Immunodeficiency Associated Lymphoproliferative Disorder: The BCCA Experience

Tissue Factor-Dependent Pro-Coagulant Activity Of Human Platelets Is Directly Related To Membrane Cholesterol Content. Rosuvastatin, But Not Atorvastatin, Reduces The Platelet Cholesterol, Tissue Factor Protein and Clotting Activity In Hypercholesterolemic Patients

Post-Transplant Lymphoproliferative Disorder in Lung Transplant Recipients – a Shift Lo Late Onset Disease

hDLG Associated Protein 1 (DLGAP1) Supports Mpl-Driven Cell Proliferation and Differentiation Through Its Centrosomal Function,

Sox4 and CREB Cooperate in Myeloid Transformation,

Integration-Mediated Activation of PRDM16 and HMGA2 in Multiple Clones without Adverse Hematopoietic Consequences Following Transplant of Autologous MGMTP140K Gene-Modified CD34 + Cells

Lymphopenia and EBER-Negativity Predict Poor Survival in Patients with Post-Transplant Lymphoproliferative Disorder (PTLD) Treated in the Rituximab Era

Relapse of Lymphoma After Allogeneic Hematopoietic Cell Transplantation: Management Strategies and Outcome.

Identification of Genes Cooperating with Mpl Signaling Using Retroviral Insertional Mutagenesis.

Angiotensin II Receptor-Associated Protein (AGTRAP) Synergizes with Mpl Signaling to Promote Survival and to Increase Proliferation Rate of Hematopoietic Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only